Islam Farzana, Agarwalla Rashmi, Panda Meely, Alvi Yasir, Singh Vishal, Debroy Arup, Ray Arindam, Vadnerkar Amruta, Uttekar Shraddha
Department of Community Medicine, Hamdard Institute of Medical Sciences and Research, New Delhi, India.
Department of Community and Family Medicine, All Indian Institute of Medical Sciences, Guwahati, Assam, India.
J Family Med Prim Care. 2021 Jun;10(6):2369-2375. doi: 10.4103/jfmpc.jfmpc_2437_20. Epub 2021 Jul 2.
Understanding the perception and concerns of people about COVID-19 vaccine in developing and populous country like India will help in understanding demand for the vaccine and further tailoring out public health information and education activities. The study was carried out to assess the present state of knowledge people have about the probable vaccine for COVID-19, to know the preferences of respondents about this vaccine and to learn the expectations and apprehensions of people about features of this prospective COVID-19 vaccine residing in the capital city of India.
This cross-sectional study was conducted amongst the residents of Delhi, India from July to October 2020. Both offline and online interview method was used to collect date from 513 participants representing various occupational strata. Data were collected on sociodemographic variable, vaccine acceptance and concerns regarding COVID-19 vaccine.
Among the study population, 79.5% said they will take the vaccine while 8.8% said they were not going to take the vaccine and remaining 11.7% had not yet decided about it. More than 50% were willing to pay for the vaccine and 72% felt vaccine should first be given to health workers and high-risk group.
The following study has helped to understand the percentage of people who are hesitant to take the vaccine and also the concerns regarding the vaccine. Also since half of the population is willing to pay for the vaccine, a strategic approach considering the various economical classes of people could be applied in a developing country like India.
在像印度这样的发展中人口大国,了解人们对新冠疫苗的认知和担忧,将有助于了解疫苗需求,并进一步定制公共卫生信息和教育活动。开展这项研究是为了评估人们对可能的新冠疫苗的现有认知水平,了解受访者对该疫苗的偏好,并了解居住在印度首都的人们对这种未来新冠疫苗特性的期望和担忧。
这项横断面研究于2020年7月至10月在印度德里的居民中进行。采用线下和线上访谈方法,从代表不同职业阶层的513名参与者中收集数据。收集了关于社会人口统计学变量、疫苗接受情况以及对新冠疫苗的担忧等方面的数据。
在研究人群中,79.5%的人表示会接种疫苗,8.8%的人表示不会接种,其余11.7%的人尚未决定。超过50%的人愿意为疫苗付费,72%的人认为疫苗应首先接种给医护人员和高危人群。
以下研究有助于了解对接种疫苗持犹豫态度的人群比例以及对疫苗的担忧。此外,由于一半的人口愿意为疫苗付费,在像印度这样的发展中国家,可以针对不同经济阶层的人群采用一种战略方法。